Daesang Holdings Q1: Consolidated Operating Profit KRW 78.1B (+48% YoY), Net Income Swings to Profit

Consolidated Q1 2026: revenue KRW 1,425.9B (+1.2% YoY), operating profit KRW 78.1B (+48.3%), net income KRW 45.4B (vs. KRW 17.9B in Q1 2025)
Standalone: revenue KRW 24.4B, operating profit KRW 19.3B, net income KRW 18.0B (all YoY increases)
Segment improvement: food operating profit KRW 41.2B, materials KRW 12.5B
Consolidated debt-to-equity ratio rose to 246.9% from 236.3% at end-2025 (increased leverage)
Completed acquisition of Amino GmbH for KRW 49.9B, expanding pharma amino acid business
Approved dividend of KRW 300 per common share (vs. KRW 270 last year), reduced capital reserve to secure payout
R&D spending KRW 16.7B (1.2% of revenue), continued new product launches
Need to watch changes in non-operating items such as equity method investment losses